Synaptogenix Inc (SNPX)

[InTheTrenches]

Safety has been somewhat proven for high-dose and short-term, but what about long-term chronic use, for a year or more? I'm assuming patients will need to take Bryostatin for the rest of their life.

I agree: if Bryostatin reverses moderate-to-severe AD and is safe to take, it could be one of the biggest selling drugs of all time, and after a year of sales, would have a market cap much greater than $10B.

If Phase 2b results are effective and squeeky-clean safe, it wouldn't be a bad move for a smart, cash-rich Pharma to make a buyout bid for $3B (realizing that there is still a lot of work to do to get to approval, with a Phase 3 and PDUFA).